sorafenib has been researched along with biochanin a in 1 studies
Studies (sorafenib) | Trials (sorafenib) | Recent Studies (post-2010) (sorafenib) | Studies (biochanin a) | Trials (biochanin a) | Recent Studies (post-2010) (biochanin a) |
---|---|---|---|---|---|
6,520 | 730 | 5,251 | 427 | 6 | 224 |
Protein | Taxonomy | sorafenib (IC50) | biochanin a (IC50) |
---|---|---|---|
Lysine-specific histone demethylase 1A | Homo sapiens (human) | 2.95 | |
Aromatase | Homo sapiens (human) | 0.0102 | |
Amine oxidase [flavin-containing] A | Homo sapiens (human) | 0.4 | |
Amine oxidase [flavin-containing] B | Homo sapiens (human) | 0.4 | |
17-beta-hydroxysteroid dehydrogenase type 2 | Homo sapiens (human) | 9.9 | |
Beta-hydroxyacyl-ACP dehydratase precursor (Fatty acid synthesis protein) | Plasmodium falciparum (malaria parasite P. falciparum) | 8 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abdel-Naim, AB; Badawy, NN; El-Ahwany, E; Khalifa, AE; Liu, AW; Tolba, MF; Youssef, MM; Zada, S | 1 |
1 other study(ies) available for sorafenib and biochanin a
Article | Year |
---|---|
Novel combination of sorafenib and biochanin-A synergistically enhances the anti-proliferative and pro-apoptotic effects on hepatocellular carcinoma cells.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Drug Synergism; Genistein; Hepatocytes; Humans; Inhibitory Concentration 50; Niacinamide; Phenylurea Compounds; Sorafenib | 2016 |